isothipendyl 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
vasodilators 1507 482-15-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • isothipendyl
  • dimethylaminoisopropylazaphenothiazine
  • isothipendyl hydrochloride
  • isothipendyl HCl
  • Molecular weight: 285.41
  • Formula: C16H19N3S
  • CLOGP: 4.13
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 0
  • TPSA: 19.37
  • ALOGS: -3.31
  • ROTB: 3

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 2.233 Moderate 0.72
caco2-efflux Caco-2 efflux ratio (BA/AB) 0.394 Moderate 0.72
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 31.477 10^-6 cm/s Moderate 0.72
dh-clint Dog hepatocyte intrinsic clearance 62.661 uL/min/10^6 cells Moderate 0.72
dppb Dog plasma protein binding (% unbound) 32.220 % Moderate 0.72
fcs-ppb Fetal calf serum protein binding (% unbound) 36.580 % Moderate 0.72
herg hERG pIC50 5.287 pIC50 Moderate 0.72
hh-clint Human hepatocyte intrinsic clearance 7.311 uL/min/10^6 cells Moderate 0.72
hlm-clint Human liver microsomal intrinsic clearance 29.580 uL/min/mg protein Moderate 0.72
hppb Human plasma protein binding (% unbound) 28.190 % Moderate 0.72
kinase-safety-class ACVR2B,AKT2,AXL,BRAF,CAMK2B,CAMK2D,CDK5,CDK9,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,JAK3,MAP3K7,MAPK10,MAPK7,MET,NTRK2,PDK2,PDK4,PIM2,PRKDC,TEK 25
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 0.466 Moderate 0.72
mh-clint Mouse hepatocyte intrinsic clearance 177.011 Moderate 0.72
mppb Mouse plasma protein binding (% unbound) 36.740 Moderate 0.72
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 1.225 Moderate 0.72
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pld-class Phospholipidosis risk class (1 = positive, 0 = negative) 1 Moderate 0.72
pppb Pig plasma protein binding (% unbound) 48.160 % Moderate 0.72
rh-clint Rat hepatocyte intrinsic clearance 233.346 uL/min/10^6 cells Moderate 0.72
rh-fuinc Rat hepatocyte fraction unbound in incubation 75.760 % Moderate 0.72
rppb Rat plasma protein binding (% unbound) 35.200 % Moderate 0.72
solubility-dd Solubility at pH 7.4 in DMSO 914.113 uM Moderate 0.72

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC D04AA22 DERMATOLOGICALS
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
Antihistamines for topical use
ATC R06AD09 RESPIRATORY SYSTEM
ANTIHISTAMINES FOR SYSTEMIC USE
ANTIHISTAMINES FOR SYSTEMIC USE
Phenothiazine derivatives
MeSH PA D006633 Histamine Antagonists
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D018494 Histamine Agents

Related Drugs by ATC class:

D04AA Antihistamines for topical use 13 drugs
bamipinechloropyraminechlorphenoxamineclemastinedimetindenediphenhydraminemepyraminepheniraminepromethazinethenalidinethonzylaminetolpropamine show all 13 →
R06AD Phenothiazine derivatives 8 drugs
alimemazinehydroxyethylpromethazinemequitazinemethdilazineoxomemazinepromethazinethiazinamthiethylperazine

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.25 Basic
pKa2 4.14 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01143 KEGG_DRUG
C0064088 UMLSCUI
CHEBI:135183 CHEBI
CHEMBL2111066 ChEMBL_ID
DB08802 DRUGBANK_ID
CHEMBL2107246 ChEMBL_ID
C008214 MESH_SUPPLEMENTAL_RECORD_UI
3781 PUBCHEM_CID
689 INN_ID
1225-60-1 SECONDARY_CAS_RN
WVZ7K9P0JY UNII
235726 RXNORM
003406 NDDF
004803 NDDF
WVZ7K9P0JY INXIGHT DRUGS

Pharmaceutical products:

None